Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloid-beta-induced mitochondrial dysfunction.

John Xi Chen1, Shi Du Yan

  • 1Harvey Cushing Institutes of Neuroscience, North Shore-Long Island Jewish Health System, Great Neck, NY 11021, USA.

Journal of Alzheimer'S Disease : JAD
|October 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Journal of Alzheimer's disease : JAD·2016
Same author

Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.

Human molecular genetics·2015
Same author

Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2014
Same author

Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction.

Free radical biology & medicine·2014
Same author

Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.

Biochimica et biophysica acta·2013
Same author

Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.

Biochimica et biophysica acta·2013

Alzheimer's disease (AD) involves amyloid-beta (Abeta) disrupting mitochondrial function. Blocking the interaction between Abeta and the ABAD enzyme may offer a new therapeutic strategy for AD.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Alzheimer's Disease Pathogenesis

Background:

  • Amyloid-beta (Abeta) is a key factor in Alzheimer's disease (AD) pathogenesis.
  • Abeta accumulation within mitochondria directly causes mitochondrial toxicity.
  • Mitochondrial dysfunction includes impaired energy metabolism, increased reactive oxygen species (ROS), and altered permeability transition pore formation.

Purpose of the Study:

  • To investigate the role of Abeta-binding alcohol dehydrogenase (ABAD) in Abeta-mediated mitochondrial dysfunction in AD.
  • To explore the therapeutic potential of blocking the ABAD/Abeta interaction.

Main Methods:

  • Localization of ABAD within the mitochondrial matrix.
  • Assessment of ABAD's binding to mitochondrial Abeta.

Related Experiment Videos

  • Evaluation of the impact of ABAD/Abeta interaction on mitochondrial and neuronal function, including synaptic function and spatial learning/memory.

    • Main Results:

    • ABAD is localized to the mitochondrial matrix and binds to mitochondrial Abeta.
    • The interaction between ABAD and Abeta exacerbates Abeta-induced mitochondrial and neuronal damage.
    • This interaction leads to impaired synaptic function and deficits in spatial learning and memory.

    Conclusions:

    • The interaction between ABAD and Abeta significantly contributes to neuronal dysfunction in Alzheimer's disease.
    • Blocking the ABAD/Abeta interaction presents a promising therapeutic target for AD treatment.
    • Targeting this specific molecular interaction could mitigate mitochondrial toxicity and improve cognitive deficits in AD patients.